|
|
|
Globestar Therapeutics Corporation (GSTC) |
|
| Industry
../Industry/industry_growth_rates.php?capx&ind=803">
• Major Pharmaceutical Preparations |
| Sector •
Healthcare |
|
|
|
Globestar Therapeutics Corporation
GSTC's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Globestar Therapeutics's sales fell
in I. Quarter 2022 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -3.83 %
Globestar Therapeutics net loss deacreased by in I. Quarter 2022 year on year, Globestar Therapeutics net loss increased by -50.15 % in I. Quarter 2022 year on year,
• More on GSTC's Growth
|
|
Globestar Therapeutics
reported net loss of -1 millions in the past twelve months.
|
| Company |
| |
|
PE TTM
|
| Industry |
|
0.01 |
|
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.45.
• More on GSTC's Valuation
|
|
|
|
|
Globestar Therapeutics
reported net loss of -1 millions in the past twelve months.
|
| Company |
| |
|
PE TTM
|
| Industry |
|
0.01 |
|
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.45.
| | | |
